ESR1 and breast carcinoma: From the study of more than 800 miRNA in ER+ en ER− breast tumors and confirmation of our results in a large validation series, we identified a robust collection of 20 miRNAs significantly deregulated in ER+ compared to ER− breast cancers: 12 up-regulated and eight down-regulated miRNAs.